摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-amino-7-(3-amino-1-pyrrolidinyl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid | 115904-58-0

中文名称
——
中文别名
——
英文名称
5-amino-7-(3-amino-1-pyrrolidinyl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
英文别名
5-amino-7-(3-aminopyrrolidin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
5-amino-7-(3-amino-1-pyrrolidinyl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid化学式
CAS
115904-58-0
化学式
C17H18ClFN4O3
mdl
——
分子量
380.806
InChiKey
YTVOXFQCURQYHX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    26
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    113
  • 氢给体数:
    3
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship
    摘要:
    A series of 5-amino- and 5-hydroxyquinolone antibacterials substituted at C7 with a select group of common piperazinyl and 3-aminopyrrolidinyl side chains was prepared. These 5-substituted derivatives were compared to the analogous 5-hydrogen compounds for antiinfective activity by using DNA gyrase inhibition, minimum inhibitory concentrations against a variety of bacteria, and in vivo efficacy in the mouse infection model. The influence on the structure-activity relationships of varied substituents at C8 (H, F, Cl) and Ni (ethyl, cyclopropyl, difluorophenyl) was also studied. The results showed that several of the structure-activity conclusions regarding side-chain bulk at C7, the effect of halogen at C8, and the effect of the C5-amino group were greatly influenced by the choice of the N1-substituent. Several outstanding broad spectrum quinolones were identified in this work. In particular, the spectrum and potency of the 7-piperazinyl quinolones could be greatly enhanced by the judicious choice of C5-, C8-, and N1-substitutents.
    DOI:
    10.1021/jm00107a039
点击查看最新优质反应信息

文献信息

  • 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial
    申请人:Warner-Lambert Company
    公开号:US04822801A1
    公开(公告)日:1989-04-18
    Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.
    描述了新型萘啉基、喹啉基和苯并噁嗪羧酸作为抗菌剂的小说,以及它们的制造、配方和用于治疗细菌感染的方法,包括用于制造抗菌剂的某些新型中间体的描述。
  • Antibacterial agents - II
    申请人:Warner-Lambert Company
    公开号:US05097032A1
    公开(公告)日:1992-03-17
    Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.
    本文描述了新型萘啶、喹啉和苯并噁嗪羧酸作为抗菌剂,以及其制备、配方和治疗细菌感染的使用方法,包括制备抗菌剂所使用的某些新型中间体的描述。
  • Substituted-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acids, derivatives thereof, pharmaceutical compositions comprising the compounds, and processes for producing the compounds
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0265230A1
    公开(公告)日:1988-04-27
    Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids of formula in which Z is are disclosed. The compounds are useful as antibacterial agents. Also disclosed is a process for producing the compounds and a pharmaceutical composition comprising the compounds.
    新颖的萘啶、喹啉和苯并噁嗪羧酸,其式为 其中 Z 为 的新型萘啶-喹啉-和苯并噁嗪羧酸。这些化合物可用作抗菌剂。还公开了生产这些化合物的工艺和包含这些化合物的药物组合物。
  • Bisphosphonate quinolone conjugates and uses thereof
    申请人:BIOVINC, LLC
    公开号:US10865220B2
    公开(公告)日:2020-12-15
    Described herein are bisphosphonate quinolone compounds, conjugates and pharmaceutical formulations thereof that can include a bisphosphonate and a quinolone, where the quinolone can be releasably coupled to the bisphosphonate. Also provided herein are methods of making and methods of using the bisphosphonate quinolone compounds, conjugates and pharmaceutical formulations thereof.
    本文描述的是双膦酸盐喹诺酮化合物、共轭物及其药物制剂,可包括双膦酸盐和喹诺酮,其中喹诺酮可与双膦酸盐可释放地偶联。本文还提供了制造和使用双膦酸盐喹诺酮化合物、共轭物及其药物制剂的方法。
  • Improved process for the preparation of 5-amino-7-(substituted amino)-quinoline-3-carboxylic acids
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0342649B1
    公开(公告)日:1994-11-30
查看更多